Perlmutter Cancer Center
-
Mid-Stage Trials Show Some Promise for Merck’s Experimental Cancer Vaccine
An experimental cancer vaccine is being developed by Lansdale-centric Merck, with input from Moderna. The project’s mid-stage trials are showing…
Founding Partners
Advertisement
Affiliate Partners
Community Partners
